IASLC - Lung Cancer Considered India
This episode of Lung Cancer Considered covers lung cancer in India and brings awareness about its first and largest advocacy group in the nation. To learn more about Lung Connect India, key members of...
7 Huhti 42min
LCC in Korean: A Case-Based Discussion on EGFR-Mutant NSCLC
As part of IASLC’s ongoing podcast series in world languages, Dr. Chul Kim moderates a discussion in Korean with Dr. Beung-Chul Ahn and Dr. Hyein Jeon. The session focuses on the clinical management o...
3 Huhti 33min
IASLC LCC - Early Stage and Preoperative Care for NSCLC and EFGR in Mandarin
In this episode, recorded in Mandarin, host Dr. Chunxia Su leads a discussion about early stage and preoperative care for patients with NSCLC with an EGFR mutation. Guests: Wenzhao Zhong, Deputy Pre...
20 Maalis 48min
IASLC - TTLC_Molecular Tumor Board
In this episode of Lung Cancer Considered, host Dr. Narjust Florez conducts three mock molecular tumor boards with Dr. Misako Nagasaka and Dr. Biagio Ricciuti, live from the Targeted Therapies of Lung...
17 Maalis 54min
Live from TTLC 2026: ADCs Controversies
In this episode of Lung Cancer Considered, host Dr. Narjust Florez and guest Dr. Sam Rosner examine controversies around antibody-drug conjugates (ADCs) live from the 2026 Targeted Therapies of Lung ...
10 Maalis 38min
LCC in French_Virtual Tumor Board - EFGR NSCLC (1)
As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Angela Botticella and Dr. Jean Yannis Perentes. The tumor board ...
6 Maalis 43min
Virtual Tumor Board: EGFR-mutant NSCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by Dr. Sara Pilotto and Dr. Jonathan Riess for a virtual tumor board discussion on the management of metastatic EGFR exon 19 N...
3 Maalis 47min
Controversies in the Management of Lung Cancer: Comorbidities
In this episode of Lung Cancer Considered, host Dr. Narjust Florez explores controversies in managing lung cancer patients with comorbidities – those often underrepresented in clinical trials – with D...
27 Helmi 48min
